Source: DiaCarta Blog

DiaCarta Blog DiaCarta and Capstone Health Alliance Collaborate to Bring Revolutionary Diagnostic Tests to Enhance Patient Care

DiaCarta, Inc., a pioneer in developing innovative molecular technologies to transform patient care by providing effective precision diagnostics using liquid biopsy in cancer and infectious diseases has established a strategic collaboration with Capstone Health Alliance, one of the largest regional group purchasing organizations (GPO) in the US healthcare sector. This new collaboration brings together powerful technologies to enhance patient care.

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Aiguo Zhang's photo - President & CEO of DiaCarta

President & CEO

Aiguo Zhang

CEO Approval Rating

50/100

Read more